Heteroaryl compounds as BTK inhibitors and uses thereof
US11098041B2 · kind B2 · utility
1Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 8, 2019 |
| Grant date | Aug 24, 2021 |
| Priority date | — |
| Expiry date | Apr 8, 2039 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D519/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Imidazo pyridine compounds, and pharmaceutically acceptable compositions thereof are useful as BTK inhibitors.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.